Abel Hall LLC’s Nkarta NKTX Stock Holding History

Abel Hall LLC’s Portfolio NKTX Stock Details NKTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$50.9K	Buy	24,113 +9,535	+65%	+$21.3K	0.01%	742
2025 Q4	$27K	Buy	+14,578	New	+$29.1K	0.01%	686

Other funds holding NKTX

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

SOCM

SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return

GSK plc London $599M AUM

MAM

Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Abel Hall LLC's NKTX Position: Q1 2026 in Review

Abel Hall LLC increased its Nkarta (NKTX) stake by 65% in Q1 2026, buying an estimated $21.3K and bringing the position to 24,113 shares worth $50.9K. The position accounts for 0.01% of the portfolio, ranked #742.

Abel Hall LLC first reported a position in NKTX in Q4 2025 and has held it in 2 quarters since. 126 funds tracked by Wall St. Rank hold NKTX as of Q1 2026.

Abel Hall LLC held 24,113 shares of Nkarta worth $50.9K as of Q1 2026.
Abel Hall LLC bought 9,535 Nkarta shares in Q1 2026, an estimated $21.3K.
Nkarta made up 0.01% of Abel Hall LLC's portfolio in Q1 2026, its #742 holding.
Abel Hall LLC first reported a position in Nkarta in Q4 2025 and has held it in 2 quarters since.
126 funds tracked by Wall St. Rank held Nkarta as of Q1 2026.

Based on Abel Hall LLC's 13F filing for Q1 2026, filed 28 Apr 2026.